Novel Therapies for Metabolic Complications in Patients With Lipodystrophies.
Phase of Trial: Phase II/III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cholic acid; Leptin; Pioglitazone
- Indications Diabetes mellitus; Fatty liver; Hypertriglyceridaemia; Insulin resistance; Lipodystrophy
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Jun 2013 Planned end date changed from 1 Aug 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned end date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.